Mapping Bromodomains in breast cancer and association with clinical outcome

Javier Pérez-Pena, Raquel Páez, Cristina Nieto-Jiménez, Verónica Corrales Sánchez, Eva M. Galan-Moya, Atanasio Pandiella, Balázs Győrffy, Alberto Ocana

Research output: Contribution to journalArticle

1 Citation (Scopus)


A specific family of proteins that participate in epigenetic regulation is the bromodomain (BRD) family of proteins. In this work, we aimed to explore the expression of the BRD family at a transcriptomic level in breast cancer, and its association with patient survival. mRNA level data from normal breast and tumor tissues were extracted from public datasets. Gene set enrichment analysis (GSEA) was performed to identify relevant biological functions. The KM Plotter Online tool was used to evaluate the relationship between the presence of different genes and patient clinical outcome. mRNA level data from HER2+ breast cancer patients sensible and resistant to trastuzumab were also evaluated. The BRD family was an enriched function. In HER2 positive tumors the combined analyses of BRD2, BAZ1A, TRIM33 and ZMYND8 showed a detrimental relapse free survival (RFS). Similarly, the combined analysis of BRD2, BAZ1A, PHIP, TRIM33, KMT2A, ASH1L, PBRM1, correlated with an extremely poor overall survival (OS). The prognosis was confirmed using an independent dataset from TCGA. Finally, no relation between expression of BRD genes and response to trastuzumab was observed in the HER2 population. Upregulation of some BRD genes is associated with detrimental outcome in HER2 positive tumors, regardless trastuzumab treatment.

Original languageEnglish
Article number5734
JournalScientific reports
Issue number1
Publication statusPublished - Dec 1 2019

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Mapping Bromodomains in breast cancer and association with clinical outcome'. Together they form a unique fingerprint.

  • Cite this

    Pérez-Pena, J., Páez, R., Nieto-Jiménez, C., Sánchez, V. C., Galan-Moya, E. M., Pandiella, A., Győrffy, B., & Ocana, A. (2019). Mapping Bromodomains in breast cancer and association with clinical outcome. Scientific reports, 9(1), [5734].